Press release
Liver Cancer Market Study Highlights How Industry Demand Is Evolving
Liver Cancer Market
Expected Market Value of the Liver Cancer Industry by 2030
The liver cancer market is predicted to experience rapid growth, reaching a valuation of $6.39 billion by 2030. This surge corresponds to a robust compound annual growth rate (CAGR) of 13.8%. Several factors are driving this upward trajectory, including the increasing prevalence of non-alcoholic fatty liver disease (NAFLD) and other metabolic disorders. Additionally, greater use of immunotherapy treatments, heightened investment in oncology research, wider availability of advanced diagnostic technologies, and growing public awareness about liver cancer risk factors contribute to this expansion. Key trends shaping the market involve a rising incidence of hepatocellular carcinoma, stronger focus on early detection and screening initiatives, broader adoption of targeted and immunotherapy treatments, growth in multimodal treatment strategies, and increased demand for specialized liver cancer care centers.
The liver cancer market size has grown rapidly in recent years. It will grow from $3.34 billion in 2025 to $3.81 billion in 2026 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to high prevalence of hepatitis b and c infections, increasing rates of liver cirrhosis, long-term alcohol consumption patterns, limited early-stage diagnosis rates, historical reliance on surgery and chemotherapy.
Download a free sample of the liver cancer market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22039&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Prominent Industry Players in the Liver Cancer Market
The liver cancer sector features several leading companies actively involved in research, development, and commercialization of therapies. Notable names include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., and Celsion Corporation.
In a recent strategic move, August 2023 saw TriSalus Life Sciences, Inc., a US-based company specializing in oncology medical technologies, merge with MedTech Acquisition Corporation. This merger is intended to strengthen TriSalus Life Sciences' financial resources and accelerate the development of innovative liver and pancreatic tumor treatments. MedTech Acquisition Corporation operates as a special purpose acquisition company (SPAC) focused on mergers within the medical technology field.
View the full liver cancer market report:
https://www.thebusinessresearchcompany.com/report/liver-cancer-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Current Trends Advancing the Liver Cancer Market
Leading companies in the liver cancer field are concentrating efforts on developing innovative therapeutic devices aimed at improving the precision of treatments such as transcatheter arterial chemoembolization (TACE). This minimally invasive technique delivers chemotherapy directly to liver tumors while blocking their blood supply, enhancing treatment efficacy and minimizing side effects.
For instance, in November 2023, Terumo Corporation, headquartered in Japan, introduced two novel therapy devices: Occlusafe and LifePearl. These products are designed to optimize liver cancer management, especially for hepatocellular carcinoma (HCC), which is the most frequently diagnosed primary liver cancer in India, with over 20,000 new cases annually. Occlusafe supports Balloon-TACE (B-TACE), a sophisticated procedure that improves precision by using a balloon to block blood flow during treatment. LifePearl consists of polyethylene glycol (PEG) embolization microspheres capable of carrying chemotherapeutic drugs directly to the tumor site.
Detailed Segmentation of the Liver Cancer Market
The liver cancer market is categorized into several segments for deeper analysis:
1) By Type:
- Hepatoblastoma
- Intrahepatic Cholangiocarcinoma
- Hepatocellular Carcinoma
- Fibrolamellar Carcinoma
2) By Stage of Liver Cancer:
- Early Stage
- Intermediate Stage
- Advanced Stage
3) By Treatment Modality:
- Targeted Therapy
- Radiation Therapy
- Surgery
- Chemotherapy
- Immunotherapy
4) By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
Each type is further broken down into subcategories:
- Hepatoblastoma includes epithelial hepatoblastoma and mixed epithelial and mesenchymal hepatoblastoma.
- Intrahepatic cholangiocarcinoma is divided into mass-forming, periductal infiltrating, and intraductal growing types.
- Hepatocellular carcinoma subtypes comprise fibrolamellar, conventional, scirrhous, clear cell, and lymphoepithelioma-like variants.
- Fibrolamellar carcinoma is segmented into classic fibrolamellar and mixed fibrolamellar and conventional hepatocellular carcinoma.
This comprehensive segmentation supports targeted research and development as well as customized treatment approaches within the liver cancer market.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Cancer Market Study Highlights How Industry Demand Is Evolving here
News-ID: 4609594 • Views: …
More Releases from The Business Research Company
Microproteins Skincare Market Report Examines Leading Companies And Growth Oppor …
The skincare industry is witnessing a remarkable surge in specialized products that target skin health at a molecular level. Among these, the microproteins skincare segment is gaining significant attention due to its promise of deeper skin penetration and enhanced anti-aging benefits. Let's explore the current market size, key players, emerging trends, and segmentation within this promising niche.
Market Size Expansion and Expectations for the Microproteins Skincare Market
The microproteins skincare…
Malignant Pleural Effusion Market Study Explores Industry Growth Toward $6.51 Bi …
The malignant pleural effusion market is set for significant expansion in the coming years, driven by advances in treatment options and a rising global cancer burden. With evolving technologies and a growing focus on patient comfort and quality of life, this sector offers promising opportunities for growth and innovation. Let's explore the market's projected size, key players, emerging trends, and core segments shaping its future.
Projected Market Value and Growth Trajectory…
Long QT Syndrome Treatment Market Demonstrates Long-Term Growth Potential At 11. …
Understanding the future outlook for the Long QT Syndrome treatment market reveals promising growth fueled by technological advancements and expanding healthcare innovations. As precision medicine and digital health tools become more integral, the market is set to evolve swiftly, offering improved care options for patients affected by this rare cardiac condition.
Projected Market Value and Growth Trajectory for Long QT Syndrome Treatment
The Long QT Syndrome treatment market is anticipated…
Microbiome Sequencing Service Market Outlook Highlights Strategic Opportunities …
The microbiome sequencing service market is rapidly evolving, driven by scientific advancements and growing demand across healthcare and research sectors. This expanding market is set to play a crucial role in personalized medicine and microbiome-based diagnostics, promising substantial growth and innovation in the coming years.
Projected Market Value and Growth Dynamics in Microbiome Sequencing Service
The microbiome sequencing service market is anticipated to reach a valuation of $5.3 billion by…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
